Global

In secret vaccine contracts with governments, Pfizer took hard line in push for profit, report says

The Manhattan-based pharmaceutical giant has maintained tight levels of secrecy about negotiations with governments, over contracts that can determine the fate of populations. The "contracts consistently place Pfizer's interests before public health imperatives," said Zain Rizvi, the researcher who wrote the report. Foto: Mark Lennihan

The coronavirus vaccine developed by Pfizer and BioNTech has proven a success. First to receive emergency use approval in the United States, the Pfizer shot has become the world's most popular, with 3.5 billion purchased. Sales could double in 2022, according to projections.

But the rapid proliferation of the vaccine, under contracts negotiated between the company and governments, has unfolded behind a veil of strict secrecy, allowing for little public scrutiny of Pfizer's burgeoning power, even as demand surges amid new negotiations for one of the world's most sought-after products...

Læs også